Advertisement
Advertisement
U.S. Markets open in 6 hrs 45 mins
Advertisement
Advertisement
Advertisement
Advertisement

Vaxart, Inc. (VXRT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.7800+0.0900 (+2.44%)
At close: 04:00PM EDT
3.7000 -0.08 (-2.12%)
After hours: 07:57PM EDT
Advertisement
Sign in to post a message.
  • J
    James
    I'm taking the chance on vxrt,it's worth the risk
  • M
    Mr
    What product does VAXFAIL have ready in market producing revenues?
  • C
    Cheri
    $50... could... very... well... be... coming... perhaps... by... December!!
    BUY... AND... HOLD... FOR THE GOLD!!
    Bullish
  • f
    fricion
    When watching the 6-22-22 Q&A Presentation: The first thing that came to mind was " I am watching Honest Faces Presenting their Truths. Vote.
  • a
    all in
    For the record, VXRT is up 4 straight days and going for 5 today.
    Will it be doable?
    Go Vaxy!
  • B
    Big Doug
    I'm still waiting for someone on this board to tell me what products Vaxart has on the market.
  • F
    Frank
    Lets cut to the chase... one question for the dougies and georgies of the board... Do you believe that vaxart will receive funds when the covid bill is eventually signed.... is money in that bill set to go to vaxart? yes or no
  • L
    LeonL
    TGIF. with Corvid-19 cases rising not only in America but UK and Canada and after the WHO and Fauci mentioned we need a 2nd generation of Corvid-19 Vaccines and the Vaccines need to
    stimulate mucosal immunity and thus is more effective in stopping transmission of virus and it'svariants. They want the development of oral vaccines global effort too.
  • a
    all in
    All of PRs from Vaxart in 2022 other than conferences and earnings:
    - Positive preliminary preclinical data protected hamsters against Omicron
    - Positive preliminary data Norovirus Phase 1b trial
    - Published the results of a Duke University-led preclinical hamster transmission study
    - S-Only Candidate Produces Strong-Cross Reactive Mucosal and Systemic Immune Responses in NHP
  • a
    all in
    Vaxart closed at $2.70 on the last Thursday and it closed at $3.78 today;
    (3.78-2.70)/2.70 * 100 = 40%. That was 40% gain in 5 trading days!
    As usual, anywhere in 2s was a buy.
  • L
    LeonL
    After listening to Vaxart board cast yesterday it is my opinion that they could be approached by Big Pharma to buy them out especially with the stock price being so low. Only my opinion.
  • a
    all in
    🚩Celebrating the 5th Consecutive Green Days🚩
    I'm not even sure if this ever happened ever for Vaxart.
    Let's go for the 6th on Monday😁
  • J
    Jackie
    Phase ll is cleared to start in India is great news.
  • P
    Paul
    Has anyone changed their mind?????
  • P
    Paul
    I’m telling you now, mucosal antibodies are the golden ticket.
    Bullish
  • C
    Cheri
    As you know...India does not require a phase III trial so approximately December would be the completion of Phase II ...
    Bullish
  • J
    Jed
    Bullish
  • J
    James
    Good conference call .
Advertisement
Advertisement